These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32725442)

  • 1. PCSK9Qβ-003 Vaccine Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Wu D; Pan Y; Yang S; Li C; Zhou Y; Wang Y; Chen X; Zhou Z; Liao Y; Qiu Z
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):141-151. PubMed ID: 32725442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Against PCSK9 Improved Renal Fibrosis by Regulating Fatty Acid β-Oxidation.
    Wu D; Zhou Y; Pan Y; Li C; Wang Y; Chen F; Chen X; Yang S; Zhou Z; Liao Y; Qiu Z
    J Am Heart Assoc; 2020 Jan; 9(1):e014358. PubMed ID: 31870234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.
    Landlinger C; Pouwer MG; Juno C; van der Hoorn JWA; Pieterman EJ; Jukema JW; Staffler G; Princen HMG; Galabova G
    Eur Heart J; 2017 Aug; 38(32):2499-2507. PubMed ID: 28637178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Therapeutic Peptide Vaccine Against PCSK9.
    Pan Y; Zhou Y; Wu H; Chen X; Hu X; Zhang H; Zhou Z; Qiu Z; Liao Y
    Sci Rep; 2017 Oct; 7(1):12534. PubMed ID: 28970592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATRQβ-001 vaccine prevents atherosclerosis in apolipoprotein E-null mice.
    Zhou Y; Wang S; Qiu Z; Song X; Pan Y; Hu X; Zhang H; Deng Y; Ding D; Wu H; Yang S; Wang M; Zhou Z; Liao Y; Chen X
    J Hypertens; 2016 Mar; 34(3):474-85; discussion 485. PubMed ID: 26771341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.
    Ason B; van der Hoorn JW; Chan J; Lee E; Pieterman EJ; Nguyen KK; Di M; Shetterly S; Tang J; Yeh WC; Schwarz M; Jukema JW; Scott R; Wasserman SM; Princen HM; Jackson S
    J Lipid Res; 2014 Nov; 55(11):2370-9. PubMed ID: 25258384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Shoushen granule on adenosine triphosphate binding cassette transporter A1, proprotein convertase subtilisin/kexin type 9 and toll-like receptor 4/nuclear factor kappa-B signaling pathway in ApoE-knockout mice.
    Li S; Cao H; Shen D; Chen C; Xing S; Dou F; Jia Q
    J Tradit Chin Med; 2019 Aug; 39(4):524-534. PubMed ID: 32186100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-α and PCSK9 in ApoE
    Li SS; Cao H; Shen DZ; Chen C; Xing SL; Dou FF; Jia QL
    Chin J Integr Med; 2020 Feb; 26(2):114-121. PubMed ID: 31144159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-chain triglycerides promote macrophage reverse cholesterol transport and improve atherosclerosis in ApoE-deficient mice fed a high-fat diet.
    Zhang X; Zhang Y; Liu Y; Wang J; Xu Q; Yu X; Yang X; Liu Z; Xue C
    Nutr Res; 2016 Sep; 36(9):964-973. PubMed ID: 27632916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of monoamine oxidase B reduces atherosclerosis and fatty liver in mice.
    Wang SH; Tsai FC; Lin HH; Yu TY; Kuo CH; Li HY; Lin MS
    Clin Sci (Lond); 2023 Jan; 137(1):17-30. PubMed ID: 36416117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice.
    Lv S; Fan R; Du Y; Hou M; Tang Z; Ling W; Zhu H
    Eur J Nutr; 2009 Jun; 48(4):205-12. PubMed ID: 19255798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
    Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
    Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fucoidan from the brown seaweed Ascophyllum nodosum ameliorates atherosclerosis in apolipoprotein E-deficient mice.
    Yin J; Wang J; Li F; Yang Z; Yang X; Sun W; Xia B; Li T; Song W; Guo S
    Food Funct; 2019 Aug; 10(8):5124-5139. PubMed ID: 31364648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
    Wu N; Li RQ; Li L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.
    Roche-Molina M; Sanz-Rosa D; Cruz FM; García-Prieto J; López S; Abia R; Muriana FJ; Fuster V; Ibáñez B; Bernal JA
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):50-9. PubMed ID: 25341796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice.
    Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y
    Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.